Associate Professor Elizabeth Scarr got her BSc honours degree in Pharmacology at Sunderland University, United Kingdom in 1989. She then moved to Canada and finished her PhD in Neuropsychopharmacology at the University of Saskatchewan in 1995. During her PhD candidature in Canada she came to realize when schizophrenia patients shared their experiences with her that she wanted to move in this field of research. She then spent a year as a post doctoral position an worked on rat hypoxic ischaemic models in Dunedin, New Zealand in 1995.
Work
After her postdoc year in New Zealand Elizabeth moved to Melbourne in 1996 and started working with human postmortem tissue at the Rebecca L. Cooper research laboratories which used to be part of the Mental Health research Institute. Elizabeth has worked as a senior research fellow at the Mental Health Research Institute.As Australian Research Council Future Fellow in the Department of Psychiatry, Elizabeth’s worked with Professor Brian Dean, who is the head of the Rebecca L. Cooper Research Laboratories at the Mental Health Research Institute. Their work lead to the identification of a subgroup of people with schizophrenia who have low levels of the protein, muscarinic M1 receptor and is known to be important in memory and attention. Currently Elizabeth Scarr is an associate professor at the Department of Psychiatry at the University of Melbourne researching the biochemistry of psychiatric disorders such as schizophrenia and bipolar disorder. She also is the project leader of Cooperative Research Centre for Mental Health and the leader of the Psychiatric Neuropathalogy laboratorium at the University of Melbourne. Her work is focused on working towards understanding chemical changes that are associated with schizophrenia and bipolar disorder in close collaboration with molecular psychiatry laboratory. She is affiliated to Australian Society for Psychiatric Research since 2006, Collegium Internationale Neuro-Psychopharmacologicum 2004, Society for Neuroscience since 2003, Australian Neuroscience Society since 1997 and the Australian Society for Medical Research 2000–2007. Her research has led to the publication of 73 peer reviewed articles and 3 book chapters so far.
Awards and honors
Recently Elizabeth Scarr has been named in the innovation category of the 100 Women of Influence 2014 by Westpac and the Australian financial review. She has been recognised for her large contribution in adding knowledge to the treatment and understanding of Schizophrenia. She is a recipient of several grants and awards. She received an award from Finkel Foundation 2003, the Collegium Internationale Neuro-Psychopharmacologicum in 2000 and the International Congress in Schizophrenia research in 1998. She has been the recipient of several major grants in the last decade.
